about
Maternal febrile illnesses, medication use, and the risk of congenital renal anomaliesAge-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcuminInhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice.High perinatal survival in monoamniotic twins managed by prophylactic sulindac, intensive ultrasound surveillance, and Cesarean delivery at 32 weeks' gestation.Drug transfer and metabolism by the human placenta.Treating common ear problems in pregnancy: what is safe?Treating common problems of the nose and throat in pregnancy: what is safe?Gynecologic malignancy in pregnancy.Hemifacial microsomia: from gestation to childhood.New problems arising from old drugs: second-generation effects of acetaminophen.Ongoing Pharmacological Management of Chronic Pain in Pregnancy.Ibuprofen-related renal tubular acidosis in pregnancy.Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit.Use of sulindac in polyhydramnios.Assessment of maternal drug intake by urinary bio monitoring during pregnancy and postpartally until the third perinatal year.Oral medication for post-Caesarean analgesia.
P2860
Q28166959-1071CD8D-F13A-433E-88E6-050CA9CD8C88Q28196338-1C1237A9-34CE-4F60-B3DE-67DDAF853F83Q33644543-368DCC88-B18F-4068-B46F-6AD1C224F927Q34568938-E7A9A13E-7206-4A10-A167-6ED46009E3B3Q35788063-495A49B8-59F8-48D2-8455-E0D4F9FA0A70Q37011834-7170BA61-31F6-43E6-980B-D9F626982CD0Q37081444-A0B282A8-DEB9-4743-A2B4-A823707C7C20Q37199991-E87D65A7-70BA-4525-BE58-2F71D0B93C6FQ37468793-81069E8D-7D46-404F-9F4A-5D5074ECA931Q38235264-E763350B-E7F5-4419-9B2B-3B6CC799C829Q38827847-01F93288-8CD5-421E-8D4D-94A59D5763D3Q41681720-5621C5EA-BFB3-4834-822B-4EDCE40649F0Q44647112-C30706F0-B0D6-4D39-AC93-D2DDC760D053Q46837569-43F377C2-0F85-4362-8173-7D4ADFE6679CQ50949045-D5D9A15C-C139-44D8-BA76-7A3EE61E7617Q51512592-B9931E71-9E7C-40DC-A253-A64CEB0D6262
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
NSAIDs: maternal and fetal considerations.
@ast
NSAIDs: maternal and fetal considerations.
@en
type
label
NSAIDs: maternal and fetal considerations.
@ast
NSAIDs: maternal and fetal considerations.
@en
prefLabel
NSAIDs: maternal and fetal considerations.
@ast
NSAIDs: maternal and fetal considerations.
@en
P2093
P2860
P1476
NSAIDs: maternal and fetal considerations.
@en
P2093
P2860
P304
P356
10.1111/J.1600-0897.1992.TB00777.X
P577
1992-10-01T00:00:00Z